Pmv Pharmaceuticals Inc (PMVP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.37
• Market Cap: $59.60M
• EPS: $-1.59
• 52-Week High: $1.84
• 52-Week Low: $0.81

Market Sentiment

Pmv Pharmaceuticals Inc currently has a Bullish sentiment score of 0.33.

About Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc. is an innovative precision oncology company headquartered in Cranbury, New Jersey, dedicated to the discovery and development of targeted small molecule therapies aimed at p53 mutations found in a range of cancers. By harnessing cutting-edge technology and in-depth insights into tumor biology, PMV seeks to transform cancer treatment paradigms with tumor-agnostic therapies, thus addressing significant unmet medical needs. The company's strategic focus on novel therape...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pmv Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PMVP pay dividends?

Pmv Pharmaceuticals Inc (PMVP) does not currently pay a regular dividend.

What is PMVP's market cap?

Pmv Pharmaceuticals Inc (PMVP) has a market capitalization of $59.60M with a current stock price of $1.37.